1. As of noon trading, Allergan ( AGN) is up $0.98 (1.1%) to $91.40 on light volume. Thus far, 649,738 shares of Allergan exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $90.49-$92.25 after having opened the day at $90.51 as compared to the previous trading day's close of $90.42. Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $26.9 billion and is part of the drugs industry. Shares are down 1.2% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Allergan a buy, no analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates Allergan as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Allergan Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more. If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).